YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones

• Published in: Biomedicines Vol. 11; no. 10; p. 2692
• Main Authors: Li, Lei, Ye, Zehua, Xia, Yuqi, Li, Bojun, Chen, Lijia, Yan, Xinzhou, Yuan, Tianhui, Song, Baofeng, Yu, Weimin, Rao, Ting, Lin, Fangyou, Zhou, Xiangjun, Cheng, Fan
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.10.2023; MDPI
• Subjects: Apoptosis; Biotechnology; Calcium oxalate; calcium oxalate crystal; Calculi; Cell death; Cell lines; Coenzyme A; Crystals; Enzymes; Epithelial cells; Ethylenediaminetetraacetic acid; Fatty acids; Ferroptosis; Fibrosis; Ischemia; Kidney diseases; kidney stone; Kidney stones; Kidneys; Lipid peroxidation; Lipids; Molecular modelling; Nephrolithiasis; Oxalates; Oxalic acid; Proteins; renal fibrosis; RNA; RNA sequencing; Transcriptomes; Verteporfin; YAP–ACSL4 axis; Yes-associated protein; China; United States > US
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines11102692

The potential association between calcium oxalate stones and renal fibrosis has been extensively investigated; however, the underlying mechanisms remain unclear. Ferroptosis is a novel form of cell death characterized by iron-dependent lipid peroxidation and regulated by acyl coenzyme A synthase long-chain family member 4 (ACSL4). Yes-associated protein (YAP), a transcriptional co-activator in the Hippo pathway, promotes ferroptosis by modulating ACSL4 expression. Nevertheless, the involvement of YAP–ACSL4 axis-mediated ferroptosis in calcium oxalate crystal deposition-induced renal fibrosis and its molecular mechanisms have not been elucidated. In this study, we investigated ACSL4 expression and ferroptosis activation in the kidney tissues of patients with calcium oxalate stones and in mice using single-cell sequencing, transcriptome RNA sequencing, immunohistochemical analysis, and Western blot analysis. In vivo and in vitro experiments demonstrated that inhibiting ferroptosis or ACSL4 mitigated calcium oxalate crystal-induced renal fibrosis. Furthermore, YAP expression was elevated in the kidney tissues of patients with calcium oxalate stones and in calcium oxalate crystal-stimulated human renal tubular epithelial cell lines. Mechanistically, in calcium oxalate crystal-stimulated human renal tubular epithelial cell lines, activated YAP translocated to the nucleus and enhanced ACSL4 expression, consequently inducing cellular ferroptosis. Moreover, YAP silencing suppressed ferroptosis by downregulating ACSL4 expression, thereby attenuating calcium oxalate crystal-induced renal fibrosis. Conclusively, our findings suggest that YAP–ACSL4-mediated ferroptosis represents an important mechanism underlying the induction of renal fibrosis by calcium oxalate crystal deposition. Targeting the YAP–ACSL4 axis and ferroptosis may therefore hold promise as a potential therapeutic approach for preventing renal fibrosis in patients with kidney stones.